After $0.5bn cumulative investment, Human Longevity Inc. pivots into high-end medical services to seek scale and ROI.
For a few years we tracked Human Longevity Inc.’s press statements and found it hard to put the pieces together to establish if progress was being made. Then in November 2019 boom: $30m investment, on top of the previous $220m Series B, led by Emerging Technology Partners.
Longevity.Technology: We expected that our interview with Human Longevity Inc.’s Chairman, Dr Wei-Wu He, would be guarded and ambiguous: not a bit of it.
Dr He was effusive and very forthcoming with details on the company’s growth plans, changing structures, science and how they plan to be at the forefront of preventative medicine – not just helping the rich live longer and healthier, but looking for scale and wide scale adoption.
The company’s beachhead is its ‘Health Nucleus’ clinic in San Diego and Human Longevity Inc. is committed to build its next clinic in the Bay Area, near San Francisco airport, followed by more clinics in major cities around the world, including London.
Here’s a link to the video on LongevityTV. Enjoy.